A--Drug Manufacturing and Formulation Program (DMFP)

SOL #: 75N95024R00077Award Notice

Overview

Buyer

Health And Human Services

National Institutes Of Health

NATIONAL INSTITUTES OF HEALTH NIDA

Bethesda, MD, 20892, United States

Place of Performance

Kansas City, MO

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

Health R&D Services; Health Care Services; Basic Research (AN11)

Set Aside

No set aside specified

Original Source

https://sam.gov/opp/24e870bb9d22432aaddff42a919f223d/view

Timeline

Posted

May 5, 2026

Last Updated

May 5, 2026

Qualification Details

Fit reasons

NAICS alignment with historical contract wins in similar service areas.
Scope strongly matches core technical capabilities and delivery model.

Risks

Past performance thresholds may require one additional teaming partner.
Potential clarification needed on staffing minimums before bid/no-bid.

Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institutes of Health (NIH), an agency under the Department of Health and Human Services, has awarded four Indefinite Delivery/Indefinite Quantity (IDIQ) contracts for the Drug Manufacturing and Formulation Program (DMFP). These awards have a maximum ordering value of $49,999,999.00 over a ten-year ordering period. Concurrently, initial task orders totaling $5,000.00 were issued to each awardee.

Scope of Work

This program supports drug manufacturing and formulation activities. The initial task orders were firm-fixed price.

Contract & Timeline

Contract Type: Indefinite Delivery/Indefinite Quantity (IDIQ) - Four (4) awards
Maximum Ordering Value: $49,999,999.00
Ordering Period: May 4, 2026, through May 3, 2036
Initial Task Orders: $5,000.00 total, effective May 4, 2026, through July 3, 2026
Set-Aside: None specified
Award Date: May 4, 2026
Published Date: May 5, 2026
Place of Performance: Kansas City, MO, United States